Genomics is a powerful tool for developing potential intervention strategies for improving outcomes in children with autism spectrum disorders (ASD) and ADHD. These often comorbid conditions may be due to many contributing factors interacting with each other, combined with the epigenetic effects of diet, lifestyle, and environment. This presentation will illustrate how understanding the function of genes and the effects of reported variants on a molecular level can be used to develop actionable and targeted potential interventions for combinations of variants. Cases will be shared to support the efficacy of this strategy and to show how these targeted interventions can be to improve ASD-related symptoms significantly.
Speaker: Heather Way, PhD
Dr. Heather Way, PhD, is the director of “The Australian Centre for Genomic Analysis.” Dr Way holds a PhD in molecular pathology and is an expert in thefield of nutrigenomics and microbiome sequencing. Dr. Heather Way, PhD, has a B. App. Sc and PhD in molecular pathology, nutrition diploma, certified nutrigenomist,
MINDD practitioner and member of the IICT. Prior to clinical practice, Dr. Way worked as a scientist with CSIRO for 25 years. She is a Ph.D. researcher with a passion for autism research. Dr. Way specializes in recovering vaccine-damaged children on the autism spectrum. Nutrigenomics enables genetic predispositions to be understood and managed via epigenetics and nutrition. Dr. Way also has two teenagers who were on the spectrum and fully recovered using her protocol. Dr. Way’s team produces personalized programs for ASD/ADHD clients all over the world, tailored to results from a specialist neurodevelopmental DNA profile that Dr. Way helped develop together with gut repair via microbiome sequencing and a fussy eating program.
